Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. 

Biotechnology

Arch Therapeutics

Terrence W. Norchi

Shawn Carlson

Evelyn Quintin

Chirag B. Shah

Richard E. Davis

Michael Abrams

The executive team at Arch Therapeutics has experience in a variety of industries, including accounting and finance, biomedical sciences, and fitness. They have also been educated at some of the top schools in the country, including the University of Chicago Booth School of Business and the University of Massachusetts Amherst.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Arch Therapeutics

Board of Directors

Leadership Team